Finally!! After years of censorship, Dr. @YaakovOphir and I managed to publish the “smoking gun” on the early cardiac safety signal for the COVID-19 vaccine in a major scientific outlet - EXCLI Journal (ranked in the 94th percentile in Biology 😱). Within just two months of the start of the vaccination campaign, Israel had already warned health authorities in the U.S. and Europe: “We are seeing a large number of myocarditis and pericarditis cases in young individuals soon after Pfizer COVID-19 vaccine.” But the data behind that “large number” never reached the public. The signal was communicated to clinicians and the public only after a delay of 3-4 months. And even then, the risk was framed as “rare, mild, and transient.” In May and June 2021, vaccination was expanded to adolescents, and ACIP concluded that the benefits of mRNA vaccines outweighed the risks, including among adolescents and young adults. Now, we expose an authentic internal pharmacovigilance dataset from the Israeli Ministry of Health, provided to us by a whistleblower: dozens of deaths and hundreds of hospitalizations, carefully documented and reported to Pfizer for over a year, from March 2021 through May 2022. Myocarditis or pericarditis appeared in nearly half of the hospitalization reports, and in more than 70% of reports involving people under 30. Among males aged 20-29, the figure was 82%, and among males under 20, it was 85%. While these percentages cannot tell us how many such events actually occurred in the population, they do show just how prominent the cardiac signal was in the Ministry’s own records. These are extremely serious findings with implications for fundamental medical ethics and regulatory decision-making. Three urgent questions demand answers: Why was vaccination expanded to younger adolescents despite the emerging cardiac safety signal? How was a categorical benefit-risk conclusion reached, especially in light of Dr. Ophir’s previous reassessment of Pfizer’s pivotal trial? And what happened to the Israeli safety data after it reached Pfizer? @SenRonJohnson @SenRandPaul Read the full paper: excli.de/excli/article/view/…